Cargando…

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

BACKGROUND: Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcomes compared to best supportive care among AGC patients who received at least two prior regimens. However, there are no reliable data regarding AGC patients with poor performance status (PS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Toshihiko, Yamamoto, Yosuke, Kuriona, Yusuke, Okazaki, Ukyo, Kimura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Mastumoto, Yusuke, Takatani, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376661/ https://www.ncbi.nlm.nih.gov/pubmed/32698781 http://dx.doi.org/10.1186/s12885-020-07176-7

Ejemplares similares

Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy
por: Ikoma, Tatsuki, et al.
Publicado: (2022)

Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
por: Matsumoto, Toshihiko, et al.
Publicado: (2022)

Real-World Data of Trifluridine/Tipiracil for Patients With Advanced Gastric Cancer: A Multi-Institutional Retrospective Study
por: Matsumoto, Toshihiko, et al.
Publicado: (2022)

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
por: Aoki, Masahiko, et al.
Publicado: (2022)

Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study
por: Hagiwara, Yuya, et al.
Publicado: (2022)

Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
por: Nakasya, Akio, et al.
Publicado: (2022)

Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in Japan
por: Takushima, Yusuke, et al.
Publicado: (2021)

Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report
por: Arigami, Takaaki, et al.
Publicado: (2020)

Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab
por: Yano, Yusuke, et al.
Publicado: (2022)

Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer
por: Iikura, Yusuke, et al.
Publicado: (2022)

A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient
por: Yatsuda, Yukino, et al.
Publicado: (2020)

Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
por: Matsumoto, Ryu, et al.
Publicado: (2020)

Multicentre biomarker cohort study on the efficacy of nivolumab treatment for gastric cancer
por: Hagi, Takaomi, et al.
Publicado: (2020)

Poor oral function is associated with loss of independence or death in functionally independent older adults
por: Nagamine, Yusuke, et al.
Publicado: (2021)

Investigation of umbilical cord serum miRNAs associated with childhood obesity: A pilot study from a birth cohort study
por: Takatani, Rieko, et al.
Publicado: (2022)

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
por: Boku, Narikazu, et al.
Publicado: (2021)

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
por: Mishima, Saori, et al.
Publicado: (2019)

Severe eosinophilia and subsequent dermatologic immune‐related adverse event with squamous cell carcinoma antigen elevation induced by nivolumab and ipilimumab
por: Matsumoto, Takeshi, et al.
Publicado: (2022)

An Autopsy Case of Late-onset Fulminant Myocarditis Induced by Nivolumab in Gastric Cancer
por: Naganuma, Ken, et al.
Publicado: (2022)

Myasthenic crisis and polymyositis induced by one dose of nivolumab
por: Kimura, Toshihiro, et al.
Publicado: (2016)

Pretreatment Glasgow prognostic score as a predictor of outcomes in nivolumab-treated patients with advanced gastric cancer
por: Tokuyama, Nagahiro, et al.
Publicado: (2021)

Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer
por: Yamasaki, Masahiro, et al.
Publicado: (2017)

Thyroid Metastasis of Gastric Cancer: A Rare Occasion With Poor Prognosis
por: Miura, Tomofumi, et al.
Publicado: (2010)

Nivolumab-related Sclerosing Cholangitis in Gastric Cancer
por: Motoo, Yoshiharu
Publicado: (2019)

Efficacy and Safety of Acetabular Cup without Screw Fixation in Total Hip Arthroplasty: A Systematic Review and Meta-Analysis
por: Miura, Takanori, et al.
Publicado: (2022)

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab
por: Senoo, Satoru, et al.
Publicado: (2018)

Nivolumab-induced interstitial lung disease in a patient with gastric cancer
por: Kimura, Akie, et al.
Publicado: (2019)

A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab
por: Tazawa, Hirofumi, et al.
Publicado: (2019)

Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity
por: Nakazawa, Nobuhiro, et al.
Publicado: (2023)

Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer
por: Miura, Tomiyuki, et al.
Publicado: (2020)

A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency
por: Sato, Yozo, et al.
Publicado: (2019)

Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans
por: Kishikawa, Hiroshi, et al.
Publicado: (2017)

Nivolumab for malignant transformation of ovarian mature cystic teratoma
por: Yoshimura, Kayoko, et al.
Publicado: (2022)

A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non–Small Cell Lung Cancer: TORG1630
por: Taniguchi, Yuri, et al.
Publicado: (2022)

Correction: Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans
por: Kishikawa, Hiroshi, et al.
Publicado: (2017)

Case Report: Complete Response of Recurrent and Metastatic Cystadenocarcinoma of the Parotid Gland With a Single Course of Combined Nivolumab and Ipilimumab Therapy
por: Nakamura, Yoshiyuki, et al.
Publicado: (2021)

Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3
por: Chin, Keisho, et al.
Publicado: (2022)

Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab
por: Fuchizawa, Hirotaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c0ftqr62trj5rdhqdhvdrla2u8